Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

Vanderbilt researchers identified optimal MRI parameters for estimating the severity of polycystic kidney disease, a common inherited disorder that can lead to end-stage renal failure.

A new technique will allow researchers to track subsets of immune cells that patrol and defend the lungs, to better understand the roles of these cells during lung inflammation, infection and injury.

Fluorescent nanoparticles clearly identified colonic adenomas — precursors to colorectal cancer — in mice, and the formulation should translate to clinical use in humans.

Raymond Burk Jr., MD, former director of the Vanderbilt's Division of Gastroenterology, Hepatology and Nutrition, died May 1 in Nashville. He was 80.

Brian Rothman, MD, has been named to the newly created role of Vice President and Executive Medical Director for Vanderbilt University Medical Center Finance.

A Vanderbilt study has identified four separate profiles to help medical professionals better assess children at elevated risk for a self-harm event.